OPHTHALMOLOGY PACS MARKET ANALYSIS

Ophthalmology Pacs Market Size and Trends

The Ophthalmology PACS market is estimated to be valued at USD 170.1 Mn in 2024 and is expected to reach USD 295.5 Mn by 2031, growing at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031. This market allows for efficient and effective imaging solutions for eye care, helping address the growing prevalence of eye diseases.

To learn more about this report, request sample copy

Ophthalmology PACS Market Trend

The ophthalmology PACS market is driven by the rising geriatric population and the subsequent increase in optic disorders. Additionally, government initiatives to modernize eye care infrastructure along with growing investments by industry players to develop advanced imaging solutions will boost the market growth. Integrating new technologies like artificial intelligence promises to further augment the efficient diagnostics and management of ophthalmic disorders.

Increasing prevalence of ophthalmic diseases

The increasing prevalence of various ophthalmic diseases across the globe is one of the primary factors fueling the growth of the ophthalmology PACS market. Eye disorders such as age-related macular degeneration, diabetic retinopathy, glaucoma, cataract, and others have been rising steadily over the past few years. For instance, according to projections by the WHO, the number of people suffering from age-related macular degeneration globally is expected to increase from 195 million in 2020 to 288 million by 2030. Diabetic retinopathy also affects over one-third of the growing diabetic population worldwide.

This upsurge in ocular diseases can partially be attributed to the rapid aging of population coupled with the rising global prevalence of conditions like diabetes that enhance the risk of associated eye disorders. Advanced age and chronic diseases make it more likely for complications to occur in the eyes over the years. Greater life expectancy has significant implications as age-related eye problems pose a huge threat. For instance, in July 2023, according to a Review of Cornea and Contact Lenses, U.S.-based researchers studied chronic age-related eye diseases in Medicare beneficiaries from 2005 to 2020. They found higher diagnosed prevalence of AMD, Age-Related Macular Degeneration diabetic retinopathy, and glaucoma compared to previous estimates. AMD prevalence rose, while any diagnosed DR decreased slightly but vision-threatening DR increased. Glaucoma prevalence decreased slightly.

Technological Advancements in Diagnostic Imaging Modalities

Ophthalmic diagnostic technologies have witnessed rapid technological upgrades in recent years. Advanced imaging modalities such as optical coherence tomography, fundus camera, and ultrasound biomicroscopy enable high-resolution visualization of internal ocular structures. These technologies generate high volume digital images and scans which need to be systematically archived, compared and evaluated by retinal specialists and ophthalmologists. Traditional film-based data storage is no longer sufficient to handle these digitally captured images effectively. PACS, Picture Archiving and Communication Systems solutions provide a digital platform to efficiently store, retrieve, share and analyze voluminous retina imaging data online. This streamlines clinical workflow and supports timely diagnosis. Continuous technological upgrades in ophthalmic imaging coupled with the need for digital image management will propel the uptake of PACS systems globally in the coming years. For instance, as per a PubMed article from May 2022, survey results revealed high performance of PACS systems in information display and reducing patient identification errors compared to paper-based methods. Ophthalmologists gave positive feedback, especially when integrated with EHR or cloud systems. Government initiatives like World Glaucoma Week, promoting awareness and early diagnosis, also contribute to market growth. Rising awareness of eye diseases like glaucoma increases ophthalmic consultations, boosting the integrated PACS system growth.